Chemotherapy-induced diarrhoea (CID) is a common adverse effect, especially with capecitabine. The majority of cases are mild. Current guidelines have recommended loperamide and octreotide for severe CID. Steroids have not been included in the current guidelines. We present a case of treatment-resistant capecitabine-induced diarrhoea, successfully managed with methylprednisolone.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843797 | PMC |
| http://dx.doi.org/10.7759/cureus.77821 | DOI Listing |
Publication Analysis
Top Keywords
diarrhoea managed
8
managed methylprednisolone
8
current guidelines
8
capecitabine-induced severe
4
severe refractory
4
refractory diarrhoea
4
methylprednisolone case
4
case report
4
report chemotherapy-induced
4
chemotherapy-induced diarrhoea
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!